FDA issued a Warning Letter to Acella Pharmaceuticals, LLC on 8/14/2020 as a result of this inspection.
483 Acella Pharmaceuticals Jan 2020

483 Acella Pharmaceuticals Jan 2020

Gideon Esuzor FDA, Veronica Fuentes FDA$119.00 - Available Now

FDA investigators audited the Acella Pharmaceuticals - Alpharetta, GA, United States facility and issued inspectional observations (via FDA 483) on 07 Jan 2020.

Product details

  • Category: Human Drugs
  • Inspection end: 07 Jan 2020
  • Location: Alpharetta, United States
  • FEI: 3006691461
Add To Cart